Skip to main content

Table 2 Changes in the Exercise on Prescription and the Control group

From: The effect of exercise on prescription on physical activity and wellbeing in a multi-ethnic female population: A controlled trial

 

EoP group intercept

Δ 6 months

Δ 12 months

Control group

Δ 6 months

Δ 12 months

Δ change 6 months between groups

Δ change 12 months between groups

Physical activity

        

 Total score

3147 (2473, 3822)

285 (−305, 875)

−88 (−660, 485)

4508 (3898, 5118)

108 (−466, 681)

−430 (−1025, 166)

177 (−646, 1001)

342 (−485, 342)

 Leisure time score

854 (647, 1062)

65 (−155, 285)

46 (−168, 261)

1296 (1143, 1449)

−251 (−412, -89)*

−386 (−556, -215)*

316 (43, 589)*

432 (158, 706)*

 Household score

2123 (1867, 2380)

118 (−110, 346)

258 (35, 482)*

2441 (2216, 2667)

−22 (−238, 193)

−54 (−279, 170)

140 (−174, 454)

312 (−4, 629)

 Work score

750 (237, 1261)

−99 (−590, 390)

−490 (−966, -13)*

815 (438, 1191)

250 (−108, 609)

−191 (−571, 190)

−350 (−957, 258)

−299 (−909, 311)

 Commuting score

93 (54, 132)

60 (8, 111)*

7 (−43, 57))

191 (150, 233)

12 (−38, 62)

−41 (−93, 11)

48 (−24, 120)

48 (−24, 120)

VO2max (ml/kg/min)

23.8 (22.9, 24.7)

0.69 (−0.42, 1.81)

0.53 (−0.56, 1.62)

24.06 (23.3, 24.9)

0.73 (−0.18, 1.63)

0.35 (−0.56, 1.26)

−0.03 (−1.47, 1.40)

0.18 (−1.24, 1.60)

BMI (kg/m2)

32.7 (31.5, 33.8)

0.37 (0.04, 0.70)*

0.28 (−0.03, 0.60)

31.4 (30.5, 32.4)

−0.08 (−0.41, 0.26)

0.35 (0.03, 0.67)*

0.45 (−0.02, 0.92 )

−0.07 (−0.52, 0.39)

Fatpercentage (%)

39.5 (38.9, 40.0)

−0.16 (−0.71, 0.38)

0.92 (0.40, 1.44)*

38.3 (37.8, 38.9 )

−0.11 (−0.66, 0.45)

0.24 (−0.30, 0.79)

−0.06 (−0.83, 0.72)

0.67 (−0.08, 1.43)

Waistcircumference (cm)

96.2 (94.2, 98.1)

−1.8 (−3.2, -0.37)*

−2.06 (−3.42, -0.70)*

94.2 (92.3, 96.0)

−1.49 (−2.8, -0.17)

−1.29 (−2.6, -0.01)

−0.31 (−2.27, 1.64)

−0.77 (−2.64, 1.11)

Mental well-being

15.8 (14.1, 17.4)

−0.06 (−1.07, 0.95)

0.35 (−0.62, 1.32)

19.5 (18.0, 20.9)

0.24 (−0.68, 1.16)

−0.00 (−0.96, 0.96)

−0.30 (−1.67, 1.07)

0.35(−1.01, 1.72)

  1. Table 2 Changes in the Exercise on Prescription and the Control Group. Δ 6 months: changes at 6 months compared to baseline, Δ 12 months: changes at 12 months compared to baseline. *; significant difference (P < 0.05).